Lonafarnib

CAS: 193275-84-2

Ref. 3D-FL24924

Información del producto

• Nombre: Lonafarnib
• Sinónimos: 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidi necarboxamideSarasarSch 66336, ( )4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta (1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxami de, 1-Piperidinecarboxamide, 4-[2-[4-[(11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-, 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide, Sarasar, Sch 66336, Zokinvy

Descripción

Lonafarnib is a selective, non-peptidomimetic competitive inhibitor of farnesyl trasferase with IC50 of 1.9nM. Farneslyl transferase is involved in post-translational lipid modifications of H-Ras, progerin and other farnesylated proteins, and plays a role in cancer as well as in a rare genetic disease known as progeria or Hutchinson-Gilford syndrome, causing premature and rapid aging.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 638.82 g/mol
• Fórmula: C₂₇H₃₁Br₂ClN₄O₂
• Pureza: Min. 95%
• InChI: InChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)
• Clave InChI: InChIKey=DHMTURDWPRKSOA-UHFFFAOYSA-N
• SMILES: NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1